1/69
Looks like no tags are added yet.
Blood components
Blood makes up 8% of total body weight (average adult has 4.5-6L of blood)
blood = cellular components (45%) and plasma components (55%)
Cellular Components
The formed elements
contains erythrocytes (RBCs) leukocytes (WBCs), and thrombocytes (platelets)
WBCs: neutrophils, monocytes, eosinophils, basophils, and lymphocytes
Plasma
pale yellow fluid → liquid extracellular matrix
is made of 92% water, 8% proteins (albumins, fibrinogen, and globulins)
Albumins
most abundant in plasma and are responsible for maintaining hydrostatic pressure
Fibrinogen
in the plasma, is the main blood clot factor
responsible for making blood clots
What % of proteins in the blood plasma is each protein?
Albumin → 54%
Globulins → 38%
Fibrinogen → 7%
All others → 1%
Blood components (% fluids in the body)
Whole blood (7%)
Blood plasma (55% of whole blood) → 7% proteins, 91.5% water, and 1.5% solutes
Other solutes: electrolytes, nutrients, gases, regulatory substances, and waste products
Formed elements (45% of whole blood) → platelets (150,000-400,000), WBCs (5,000-10,000), and RBCs (4.8-5.4 mil)
WBC counts: neutrophils (60-70%), lymphocytes (20-25%), monocytes (3-8%), eosinophils (2-4%), and basophils (0.5-1%)
Functions of blood
transport O2, CO2, hormones, nutrients, and metabolic waste products
regulate body temperature and acid-base balance
carry cells and antibodies that fight infections
Centrifugation
process of separating blood into its components parts
blood is placed into “spring device” and put into 2 components: blood and plasma
performed in the lab before testing
steps:
withdraw blood and place in tube
centrifuge the blood sample
spins it
separates the plasma and formed elements (buffy coat in between)
Plasma and serum
plasma → fluid of unclotted blood
serum → fluid of clotted blood that contains fibrinogen
Leukocytes (WBCs)
immune cells that protect the body against infections, foreign substances, and disease
they are classified as granular (contains granules - vesicles that appear when the cells are stained and agranular (no granuels)
neutrophils, eosinophils, and basophils are GRANULAR
monocytes and lymphocytes are AGRANULAR
Neutrophils
the most abundant and is responsible for destroying bacteria through phagocytosis
Eosinophils
fights parasites (1-5% of WBCs)
involves in allergic reactions
Basophils
releases histamine and heparin
participates in inflammation and allergic response
Monocytes (+ macrophages)
monocytes circulate in bloodstream
turn into macrophages when they reach the tissues, they are responsible for engulfing pathogens by phagocytosis)
macrophages → T cells (coordinate immune response) and B cells (produce antibodies)
NK Cells
natural killer cells
they are part of innate immunity
Hematopoiesis
formation and development of RBCs in the body
occurs in bone marrow
Leukopoiesis
the process of producing WBCs in the bone marrow
the pluripotent stem cells give rise to lymphoid stem cells and myeloid stem cells
lymphoid stem cells differentiate into NK progenitor cells (makes NK cells), T-cell progenitors (makes T-cells), and B-cell progenitors (makes B-cells)
myeloid stem cells differentiate into monocytes, granulocytes (makes eosinophils, neutrophils, and basophils), megakaryocyte (makes platelets), and erythrocytes (makes RBCs)
Are there only mature cells in bone marrow?
yes
Hematopoietic growth factors
they are hormone like regulatory molecules that help in the survival, differentiation, and proliferation of progenitor cells, as well as the functional activation of mature cells
Lineage-specific growth factors
stimulate development of specific WBC types
granulocyte colony-stimulating factors - stimulates the production of neutrophils
macrophage colony-stimulating factors - stimulates the development of monocytes and macrophages
interleukin-5 (IL-5) - promotes the growth and development of eosinophils (usually happens during the allergic response)
interleukin-7 (IL-7) - supports the development of lymphocytes, especially B and T cells
Differential WBC count
measures the percentage and absolute # of each type of leukocytes in the blood
Shift to the left
refers to an increase in immature neutrophils (bands) in the peripheral blood, indicating that the bone marrow is releasing neutrophils early in response to increased demand
during a left shift, the bone marrow releases more band neutrophils and occasionally metamyelocytes and myelocytes in severe in cases
Normal neutrophil maturation
myeloblast → promyelocyte → myelocyte → metamyelocyte → band neutrophil → segmented (mature) neutrophils
can differentiate band and segmented by the shape and structure of the nucleus
Lymphatic system (contains and functions)
contains lymphatic vessels, lymph nodes, lymphoid tissues, thymus, and spleen
functions:
defends the body against pathogens
produces and matures lymphocytes
filters lymph and blood
supports adaptive (specific) immunity
Lymph nodes
filter and clean lymph, house WBCs
adaptive (specific) immunity
Priamry lymphoid tissues
where the lymphocytes become mature and immunocompetent
bone marrow → site of maturation of B-cells and the development of progenitor cells
thymus → site of maturation of T-cells
Secondary lymphoid tissues
where lymphocytes are activated by antigens
lymph nodes → site of lymph filtration
spleen → white pulp and red pulp
white pulp contains concentrated areas of B cells and T cells
red pulp contains venous sinuses that filter blood by removing pathogens and senescent erythrocytes
MALT → non-encapsulated lymphoid tissue in the GI tract, respiratory tract, and genitourinary system
Afferent and Efferent Lymph Nodes
afferent lymph channels bring lymph to the lymph node
efferent lymph channels bring lymph away from the lymph nodes
Capsule
on the spleen
can rupture during trauma
Are non-malignant or malignant disorders more common?
non-malignant
-penia
refers to decreased number of cells
-cytosis
refers to increased number of cells
Absolute neutrophil count (ANC)
actual # of neutrophils circulating in the blood
(segs + bands x WBCS)/100 = ANC
WBC = total white blood cell count
segs = % mature neutrophils
bands = % immature neutrophils
Leukopenia
decrease in the total # of WBCs in the blood
most commonly involves neutrophils leading to neutropenia
Neutropenia
abnormally low # of neutrophils in the blood
ANC < 1000 cells/microliters
normal range: 2,000-7,000
increased risk of infection
Agranulocytosis
nearly complete absence of neutrophils
extremely high risk of life-threatening infection
an ANC < 100 is a medical emergency
Congenital and Acquired Neutropenia
congenital → present at birth due to genetic disorders affecting neutrophil production
acquired → develops later in life due to chemotherapy, viral infections, autoimmune disease bone marrow disorders
these cause the patients to become prone to recurrent infections (usually bacterial or fungal (candidiasis))
common features include → frequent or recurrent infections and fever
treatment → antimicrobial agents, specific hematopoietic growth factors (e.g., GM-CSF)
Neutrophilic Leukocytosis (granulocytosis)
abnormally increased WBC count
caused mainly by an increase in neutrophils
more than 7,500 /µL
Normal range: 2,000-7,000/µL
Causes of neutrophilic leukocytosis
the most common cause of neutrophilic leukocytosis is bacterial infections because they stimulate bone marrow
evident in the first stages of infection or inflammation
other causes are inflammation, corticosteroid use, certain blood cancers (leukemia)
if the need for neutrophils increases beyond the supply, then the immature neutrophils are released into the blood
premature release of immature leukocytes is termed a shirt-to-the-left
Lymphocytopenia (lymphopenia)
abnormally low number of lymphocytes in the blood
less than: 1,000/µL
normal range: 1,000-4,500/µL
common causes
inherited genetic disorders
chemotherapy and radiation therapy → destroys cell WBCs and red blood cells
viral infections → ex) HIV destroys T-helper cells
lymphocytopenia can cause patients to become prone to recurrent infections because initial infections may not be fully eliminated, allowing pathogens to persist and cause repeated infections
treatment - antimicrobial agents, IV immunoglobulins
Lymphocytic Leukocytosis
increased total WBC count caused mainly by an increase in lymphocytes
more than: 4,500/µL
normal range: 1,000-4,500/µL
common causes:
infectious mononucleosis → most common
specifically targets lymphocytes and causes production of abnormal lymphocytes (immune-mediated response)
chronic immune mediated inflammation
chronic lymphocytic leukemia
treatment - focus on the underlying cause
Malignant Lymphomas
solid malignant tumors originating in the peripheral lymphoid tissues (typically lymph nodes)
two main categories:
Hodgkin’s lymphomas (HLs) → originate in a single lymph node or a group of adjacent lymph nodes (mainly in neck, chest, or armpits — more superficial)
Non-Hodgkin’s lymphomas (NHLs) → originate in multiple lymph nodes or multiple groups of lymph nodes (mainly in armpits, chest, abdomen, or groin)
Non-Hodgkin Lymphomas
heterogenous group of cancers affecting lymphocytes like B, T, and NK cells
they originate from lymphocytes at different stages of development
disruption of normal lymphocyte maturation can result in various NHL subtypes
exact causes are unknown
associated infectious agents include: epstein-barr virus (EBV) and human T-lymphotropic virus type 1 (HTLV-1)
Mature B-cell Lymphomas
most common subtype of NHLs
originate from germinal center of B cells or activated B cells that have exited the germinal center
varies in aggressiveness
common types include:
follicular lymphoma - indolent (slow-growing), less aggressive, does not respond well to treatment
normal lymph node architecture is replaced by malignant lymphoid follicles in a back-to-back pattern
diffuse large B-cell lymphoma (DLBCL) - aggressive, fast growing, most common between 60 and 70 years; responds better to treatment
mantle cell lymphoma - aggressive, characterized by rapid disease progression and poor prognosis; aggressive but not as aggressive as diffuse
Burkitt Lymphoma
highly aggressive B-cell NHL; fast growing tumor of the jaw and facial bones
classified based on geographic location
Endemic (African) — primarily affects children, common in equatorial Africa; very closely associated with EBV (100% of patients with African Burkitt Lymphoma have EBV)
Sporadic — occurs worldwide
less frequently associated with EBV, very rare
NHL Manifestations and testing
Manifestations
localized or painless lymphadenopathy (enlargement of lymph nodes)
nodal enlargement and transformation over months or years
retroperitoneal and abdominal masses with symptoms of abdominal fullness and back pain
ascites (fluid in the peritoneal cavity) and leg swelling
Diagnostic Testing
Biopsy
B symptoms
systemic symptoms that are in advanced stages of disease and are associated with a poorer prognosis
Hodgkin Lymphoma
distinguished by the presence of an abnormal Reed-Sternberg Cell
they are the hallmark feature used to diagnose
common in 15-40 year olds and 55 years and older
Manifestations
enlarged painless lymph nodes
lymphadenopathy, causing pressure or obstruction
mediastinal mass
fever, weight loss, night sweats, pruritus, and fatigue
Looks like two “owl’s eyes” surrounded by a red nucleolus
Stages of Hodgkin Lymphoma
also called ann arbor staging
Stage 1 → involvement of single lymph nodes or group of nodes (usually cervical, nodes are in the same region)
Stage 2 → involvement of two or more sites on the same side of the diaphragm
Stage 3 → disease on both sides of diaphragm; may include spleen or localized extra nodal disease
Stage 4 → widespread extralymphatic involvement (liver, bone marrow, lung, skin)
Leukemias
malignant neoplasms of hematopoietic precursor cells
characterized by uncontrolled growth of immature WBCs
abnormal replacement of bone marrow cells, affecting blood cell production
approx. 60,000-62,000 new cases diagnosed annually
most common cancer in children and adolescents
accounts for approx. 29% of childhood cancers
Leukoemia Classifications
predominant cell type
lymphocytic (lymphoid)
myelogenous (myeloid) → mostly affects granulocyte
disease progression
acute → rapid onset (fast); causes death in about 6 months w/o treatment
chronic → slow progression; causes death in 2-3 years without treatment
French-American British (FAB) Classification identifies 4 major types
ALL - acute lymphocytic (lymphoblastic) leukemia
CLL - chronic lymphocytic leukemia
AML - acute myelogenous (myeloblastic) leukemia
CML - chronic myelogenous leukemia
Acute Leukemia
presence of undifferentiated or immature cells, usually blast cells
sudden onset with rapid progression with short survival
symptoms severe and develop quickly
acute leukemia can never become chronic
common in children and young adults
Chronic Leukemia
predominant cells is mature but does not function normally (you can see myleocytes and other mature cells but not blast cells)
slow, gradual onset with slow progression
symptoms mild or absent initially - develop over months or years
chronic can become acute
Lymphocytic Leukemias
origin: develop form immature lymphocytes and their precursor cells in bone marrow
common sites of infiltration: spleen, lymph nodes, CNS
clinical consequences: impairs normal immune function and lymohcyte production
Myelogenous Leukemias
origin: arise from pluripotent myeloid stem cells in the bone marrow
interferes with the maturation of: granulocytes, erythrocytes and thrombocytes
clinical consequences: increased risk of infection, anemia, bleeding tendencies
Etiology of Leukemia
exact cause is unknown, but we know that it develops due to genetic and environmental factors
leukemia has molecular basis → due to disruption of genes and chromosomal abnormalities controlling blood cell development, growth, and survival; this leads to uncontrolled production of abnormal blood cells
molecular research has improved
diagnosis and classification into specific subtypes
targeted treatment selection
monitoring of treatment response and disease progression
people with chromosomal disorders are more susceptible
Acute Lymphocytic Leukemia (ALL)
most common childhood leukemia
greater than 30% of lymphoblasts in bone marrow or blood
predisposing factors:
radiation exposure, previous chemotherapy
genetic disorders like down syndrome
age → most common in children especially during ages 2-5
Acute Myelogeneous leukemia (AML)
most common in adults (older than age 50)
greater than 20% myeloblasts in bone marrow or blood
predisposing factors:
exposure to radiation
benzene
chemotherapy
Common manifestations of ALL and AML
fatigue due to anemia
low grade fever and night sweats
weight loss
easy bruising and bleeding due to thrombocytopenia (abnormally low blood platelet count)
bone pain and tenderness from bone marrow expansion
frequent infections caused by neutropenia
physical findings
lymphadenopathy → enlargement of the lymph nodes due to infiltration of leukemic cells
splenomegaly and hepatomegaly → enlargement of spleen and liver
Complications of Acute Leukemia
Leukostasis → blast count exceeds approx. 100,000 cells/µL; this causes increased blood viscosity; immediate treatment required (leukapheresis to remove excess blast cells and prevent organ damage)
CNS → leukemic cells can cross the blood-brain barrier and infiltrate the CNS (mostly the brain); requires aggressive treatment
Hyperuricemia → abnormally high amounts of uric acid in the blood; rapid destruction of leukemic cells during chemo results in release of purine nucleotides increased uric acid production
Diagnosis and treatment of acute leukemia
diagnostic tests → peripheral blood smear; bone marrow tests
treatment →
chemo → childhood leukemias respond better if they are treated early
supportive measures → blood transfusions, antibiotics, antifungals, antivirals
stem cell transplant
bone marrow transplant → approx. 45-50% develop GVHD
Chronic Lymphocytic Leukemia
affects monoclonal B lymphocytes; most common in adults in the western world
disease progression
indolent - slow-progression form; often asymptomatic and discovered incidentally on routine complete blood count
aggressive - rapidly progressing form; enlarged lymph nodes, spleen, and liver; fatigue, fever, and weight loss
Chronic Myelogenous Leukemia
begins when a single pluripotent hematopoietic stem cells acquires a genetic mutation; cells affected by CML are granulocytes (predominant leukemic cells), erythroid precursors, megakaryocytes
nearly all patients with CML have Philadelphia chromosome (chromosomal translocation from 9 to 22) that results in formation of the BCR-ABL 1 fusion gene and production of abnormal tyrosine kinase enzyme (uncontrolled proliferation of myeloid cells and reduced apoptosis)
CML Manifestations
chronic phase - lasts 2-5 years; symptoms may not be apparent, mild fatigue and leukocytosis
accelerated phase - lasts 6-18 months; primary symptoms are splenomegaly; weight loss, fever, rising blast cells
terminal blast phase - blast crisis; high # of blast cells present in blood, resembles acute leukemia (severe infections, bleeding, and bone pain); survival: only 3-6 months
Multiple Myeloma (MM)
cancer of plasma cells (terminally differentiated B lymphocytes)
abnormal plasma cells multiply uncontrollably in the bone marrow and replace normal bone marrow cells
MM most commonly affects adults over 60 years old
MM Continued
the malignant plasma cells produce excessive amounts of abnormally monoclonal immunoglobulins (M proteins)
IgG: approx. 60% of cases
IgA: approx. 20-25% of cases
bence jones proteins are free light chains immunoglobulin produced by malignant plasma cells (this is specific to MM and can cause kidney failure)
found in approx. 15-20% of MM
excess bence jones proteins are filtered through kidneys
accumulate in the renal tubules cause tubular obstruction
MM Manifestations
mainly affects the skeletal system and bone marrow
in bones, osteoclasts become overactive, causing excessive bone breakdown
development of osteolytic lesions, pathological fractures and bone pain
bone destruction releases calcium into the bloodstream, causing hypercalcemia
abnormal plasma cells produce paraproteins that can increase blood viscosity (causing kidney dmg, heart failure)
plasmacytomas - collections of malignant plasma cells forming tumors in GI tract + bones
MM Manifestations Pt 2
persistent bone pain
fatigue and weakness
weight loss
anemia
recurrent bacterial infections
renal insufficiency (proteins producing kidney obstructions)
hypercalcemia
neurological symptoms from spinal cord compression
MM Diagnosis and Treatment
diagnostic triad
bone marrow plasmacytosis → more than 10% of plasma cells in the bone marrow
lytic bone lesions → areas of bone destruction seen on X-rays
monoclonal proteins (M-protein) → areas of bone destruction seen on X-rays
treatment
chemo
prednisone (corticosteroid)
new targeted therapies and immunotherapies